Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.210 +0.150 (+7.28%)
Streaming Delayed Price Updated: 2:41 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Aytu BioPharma Announces Continuing Availability of ADHD Medication Adzenys XR-ODT(R) in Response to Reported Generic Adderall(R) XR Supply Disruptions
Via ACCESSWIRE
News headline image
Aytu BioPharma's Return On Capital Employed Insights ↗
According to data from Benzinga Pro, during Q4, Aytu BioPharma's (NASDAQ:AYTU) reported sales totaled $27.45 million. Despite a 66.65% increase in earnings, the company posted a loss of $17.70... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
Via Benzinga
News headline image
Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue
Via ACCESSWIRE
News headline image
Earnings Scheduled For September 27, 2022 ↗
Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is projected to report quarterly earnings at $2.79 per share on revenue of $7.86 billion. 
Via Benzinga
News headline image
Aytu BioPharma Announces Addition of Fourth Patent License for AR101/Enzastaurin
Via ACCESSWIRE
News headline image
Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin
Via ACCESSWIRE
News headline image
Aytu BioPharma's Earnings: A Preview ↗
Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Aytu... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million. 
Via Benzinga
News headline image
Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
  
Via Benzinga
News headline image
Aytu BioPharma to Participate in September 2022 Investor Conferences
Via ACCESSWIRE
News headline image
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Aytu BioPharma Announces Closing of $10.0 Million Registered Public Offering
Via ACCESSWIRE
News headline image
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
News headline image
Dow Drops Over 100 Points; Verona Pharma Shares Jump ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
News headline image
Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
News headline image
Aytu BioPharma Announces Pricing of Public Offering
Via ACCESSWIRE
News headline image
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today! 
Via InvestorPlace
News headline image
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket ↗
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
  
Via Benzinga
News headline image
Aytu BioPharma Announces Launch of Public Offering
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.